A multidrug efflux phenotype mutant of Streptococcus pyogenes

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 3, 2003, Pages 707-710

  Jones, H E ^a   Brenwald, N P ^a   Owen, K A ^a   Gill, M J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIFLAVINE; ANTIBIOTIC AGENT; AZITHROMYCIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; ETHIDIUM BROMIDE; GEMIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESCINNAMINE; RESERPINE; VERAPAMIL;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TRANSPORT; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; STRAIN DIFFERENCE; STREPTOCOCCUS PYOGENES;

DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, MDR; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; PHENOTYPE; STREPTOCOCCUS PYOGENES;

EID: 0037340632     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg121     Document Type: Article

References (11)

1. Baranova, N. N. & Neyfakh, A. A. (1997). Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 41, 1396-8.
2. Gill, M. J., Brenwald, N. P. & Wise, R. (1999). Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 43, 187-9.
3. Guerin, F., Varon, E., Hoi, A. B., Gutmann, L. & Podglajen, I. (2000). Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci. Antimicrobial Agents and Chemotherapy 44, 2197-200.
4. Ferrándiz, M. J., Oteo, J., Aracil, B., Gómez-Garcés, J. L. & De La Campa, A. G. (1999). Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci. Antimicrobial Agents and Chemotherapy 43, 2520-3.
5. Yan, S. S., Fox, M. L., Holland, S. M., Stock, F., Gill, V. J. & Fedorko, D. P. (2000). Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance. Antimicrobial Agents and Chemotherapy 44, 3196-8.
6. Brenwald, N. P., Gill, M. J. & Wise, R. (1998). Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 42, 2032-5.
7. Neyfakh, A. A., Borsch, C. M. & Kaatz, G. W. (1993). Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrobial Agents and Chemotherapy 37, 128-9.
8. Ahmed, M., Borsch, C. M., Neyfakh, A. A. & Schuldiner, S. (1993). Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. Journal of Biological Chemistry 268, 11086-9.
9. Boos, M., Mayer, S., Fischer, A., Köhrer, K., Scheuring, S., Heisig, P. et al. (2001). In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes and Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 45, 938-42.
10. Van Veen, H. W., Putman, M., Margolles, A., Sakamoto, K. & Konings, W. N. (2000). Molecular pharmacological characterization of two multidrug transporters in Lactococcus lactis. Pharmacology and Therapeutics 85, 245-9.
11. De Azavedo, J. C., Yeung, R. H., Bast, D. J., Duncan, C. L., Borgia, S. B. & Low, D. E. (1999). Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrobial Agents and Chemotherapy 43, 2144-7.